This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Innovator Carolyn E. Mountford: Pioneering Advances in Breast Cancer Diagnosis
Introduction: Carolyn E. Mountford, based in Easy Ryde, Australia, is a notable inventor recognized for her groundbreaking contributions to the field of medical diagnostics. With a specific focus on magnetic resonance spectroscopy, her work has significantly advanced the ability to classify breast cancer pathology.
Latest Patents: Mountford holds a patent titled "Magnetic resonance spectroscopy of breast biopsy to determine pathology, vascularization and nodal involvement." This innovative method employs robust classification techniques to analyze magnetic resonance spectroscopy (MRS) data from fine needle aspirates taken from breast tumors. By comparing the resultant data against histopathology and clinical criteria, Mountford’s technology offers a computerized classification-based diagnosis and prognosis with exceptional accuracy and reliability. The system achieved an overall accuracy of 93% in distinguishing malignant tissue from benign lesions, 95% in predicting lymph node involvement, and 92% in assessing tumor vascularization.
Career Highlights: Carolyn Mountford's career is distinguished by her commitment to improving breast cancer diagnostics. Her patent represents an important leap in utilizing advanced spectroscopy techniques to enhance diagnostic accuracy. The three-stage classification strategy she developed involves pre-processing MR magnitude spectra, cross-validated Linear Discriminant Analysis, and aggregation through Computerized Consensus Diagnosis, showcasing her thorough approach to innovation in medical technology.
Collaborations: Mountford has worked alongside esteemed colleagues, including Peter Russell and Ian C.P. Smith, to advance the research and development of her patented technology. Their collaborative efforts have contributed to the successful application of MRS in clinical settings, reinforcing the importance of teamwork in scientific innovation.
Conclusion: Carolyn E. Mountford stands out as a trailblazer in the realm of medical diagnostics, particularly in the evaluation of breast cancer through advanced magnetic resonance techniques. Her patent not only reflects her innovative spirit but also demonstrates the significant impacts her work can have on patient diagnosis and treatment planning. As the medical field continues to evolve, contributions like those of Mountford will remain instrumental in enhancing healthcare outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile